Leukocyte alkaline phosphatase expression on circulating granulocytes from representative subjects. (A) Healthy subject. (B) Patient with PV carrying 98% of JAK2 (V617F) mutant alleles in circulating granulocytes. (C) Healthy stem cell donor given G-CSF 24 hours before.